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Dear Editor,
Blunt cardiac injury (BCI) is com-
monly associated with major thoracic
trauma and influences morbidity and
mortality to a great extent [1, 2].
Despite much discussion in recent
years, no diagnostic ‘‘gold standard’’
exists. Therefore the primary aim of
this study was to evaluate the diag-
nostic significance of high sensitivity
troponin measurements in patients
with BCI. In our cross-sectional ana-
lysis, all patients admitted with
trauma were included for whom high
sensitivity serial measurements had
been performed of troponin T
between 1 August 2010 and 31
October 2012 at the Department of
Emergency Medicine (ED),
Inselspital.
Blunt cardiac trauma was sus-
pected in 31 of 86 patients admitted
with trauma. For an overview of
patient characteristics see Table 1.
The median injury severity score
(ISS) and injury count were signifi-
cantly higher in patients with BCI
(9.13, SD 9.53, p \ 0.001 and 4.71,
SD 2.5, p \ 0.0001, respectively).
The difference between the first and
second high sensitivity troponin T
measurements was significantly
higher in patients with clinically sus-
pected BCI than in others (0.003 lg/l,
interquartile range (IQR) 0.00–0.12
and 0.002 lg/l, IQR 0.00–0.005,
p \ 0.001, respectively). Neither
ECG changes of any type nor
arrhythmia or cardiac shock corre-
lated with the high sensitivity
troponin T value on admission
(p \ 0.14, p \ 0.25, p \ 0.35,
respectively) or at 3 h (p \ 0.24,
p \ 0.65, p \ 0.33, respectively) or
with the change in the high sensitivity
troponin T value (p \ 0.76, p \ 0.54,
p \ 0.41, respectively). The change
from the first to the second high
sensitivity troponin T measurement
was positively correlated with the ISS
(p \ 0.04). An increase of 20 % or
more in high sensitivity troponin T
has a sensitivity of 54.8 %, a speci-
ficity of 69.1 % and a positive
likelihood ratio of 1.77 for clinically
suspected BCI. The combination of
an increase in high sensitivity tropo-
nin T of more than 20 % and ECG
changes has a sensitivity of 64.5 %
and a specificity of 53.3 % and a
positive likelihood ratio of 1.36 for
clinically suspected BCI.
Patients without BCI less often
have positive high sensitivity tropo-
nin T values at the second
measurement than patients with clin-
ically suspected BCI. This pattern is
explained by the prolonged release of
the protein from injured myocardial
cells [2]. It has been reported that,
after severe myocardial damage,
protein release may be prolonged by
myocardial hypoxia caused by
microvascular injury [2, 3]. Never-
theless and contrary to other studies
on conventional troponin T [1, 2],
patients in our study with and without
clinically suspected BCI did not sig-
nificantly differ in baseline high
sensitivity troponin T values. This
may result from the lower specificity
of high sensitivity troponin T for
myocardial necrosis compared to
conventional troponin T [4]. Even
though high sensitivity troponin T
measurements have 10- to 15-fold
higher sensitivity for detection of
myocardial damage than conventional
troponin measurements, they more
often detect elevated values caused
by non-ischemic causes such as sep-
sis, pulmonary embolus or renal
failure [4, 5].
Our findings suggest that high
sensitivity troponin T measurement in
trauma patients is a reliable biologic
marker for estimating myocardial
injury. But because of its low speci-
ficity, not the actual value but more
the dynamics should be considered
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when assessing patients with sus-
pected BCI.
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Table 1 Patients characteristics
Total (N, %) Suspected BCI (N, %) No suspected BCI (N, %) p value
N 86 (100) 31 (36.0) 55 (64.0)
Male/female 61 (70.9)/25 (29.1) 25 (41.0)/6 (24.0) 36 (59.0)/19 (76.0) 0.21
Age (median, range) 71 (19–94) 63 (19–93) 79 (20–94) 0.089
Type of accident
Traffic accident 29 (33.7) 20 (68.9) 9 (31.1) 0.0001
Fall 57 (66.3) 11 (19.3) 46 (80.7) 0.0001
Mean AIS (mean, SD)
Thorax 1.77 (0.71) 1.77 (0.71) *
Abdomen 2.25 (1.25) 3.0 (1.41) 1.50 (0.7) 0.0001
Head 1.43 (0.78) 1.07 (0.25) 1.52 (0.94) 0.0001
Face 1.32 (0.47) 1.13 (0.35) 1.39 (0.49) 0.001
Spine 2.71 (1.38) 3.60 (0.89) 2.22 (1.39) 0.045
Upper extremities 1.38 (0.66) 1.56 (0.88) 1.25 (0.45) 0.015
Lower extremities 1.93 (0.78) 2.00 (0.81) 1.9 (0.78) 0.89
External 1.14 (0.53) 1.50 (1.00) 1.00 (0.00) 0.0001
ISS (median, range) 4 (1–41) 9.13 (9.53) 5.44 (4.77) 0.001
ECG changes at admission 21 (24.4) 5 (23.8) 16 (76.2) 0.2
Hospitalisation
Outpatient/inpatients 46 (46.5)/40 (53.5) 15 (37.5)/16 (34.8) 25 (62.5)/30 (65.2) 0.82
In-hospital mortality 3 (3.5) 1 (33.3) 2 (66.7) 0.92
Total (median, IQR) Suspected BCI (median, IQR) No BCI (median, IQR) p value
Troponin 1 (lg/l) 0.016 (0.005–0.027) 0.011 (0.004–0.24) 0.016 (0.006–0.027) 0.27
Troponin 2 (lg/l) 0.021(0.008–0.037) 0.019 (0.006–0.055) 0.022 (0.012–0.037) 0.008
Delta troponin (lg/l) 0.0020 (0.00–0.006) 0.003 (0.00–0.12) 0.002 (0.00–0.005) 0.001
Creatinine kinase (U/l) 187 (88.25–411.00) 192.5 (99.5–423.75) 165 (74.0–341.75) 0.11
MDRD 73.00 (60.0–91.50) 86.5 (63.5–96.25) 71.0 (58.0–84.0) 0.81
MDRD modification of diet in renal disease
* Only two per category
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